Tuesday, 28 September 2010

"Huff" gets onto Apology

Wow!
The Huffington Post, ranked the most powerful blog in the world by The Observer, today is featuring a huge item by Diana Bianchini about the need for a DES apology from the US Government.

See it now - One of America's Deepest Darkest Family Secrets: The DES Drug Disaster at
http://www.huffingtonpost.com/diana-biachini/one-of-americas-deepest-d_b_740798.html

Please note the statement: "A U.S. apology would also raise global awareness about DES."

Now we urge you to post comments under the DES article to let everyone know about the DES problems in Australia! Here is a chance to "let fly"!!

If you haven't already written to the US Senators to help make the Apology happen, their addresses are at previous blog "US Push for DES Apology".

Saturday, 18 September 2010

US Push for DES Apology





See blog post:
http://celebritiesindisgrace.wordpress.com/2010/09/16/sorry-seems-to-be-the-hardest-word-where-is-the-public-apology-for-des-the-worlds-first-drug-disaster-by-caitlin-mccarthy/

US screenwriter, Caitlin McCarthy (DES daughter) has a new blog post on acclaimed author Elizabeth Searle's site entitled SORRY SEEMS TO BE THE HARDEST WORD: Where is the Public Apology for DES, the World's First Drug Disaster? This blog post is a must see for anyone concerned about justice regarding DES exposure.

Caitlin's arguments are forthright and strong as she describes her lobbying on the issue of apology for DES with the Massachusetts Senators Kerry and Brown. You don't have to live in USA to voice your support and Caitlin provides options and the contacts in USA for us here in Australia to have a say.

HOW IS THIS RELEVANT TO AUSTRALIA?
There is potential for Australian media interest in the Public Apology for DES, with some real flow on benefits for the DES exposed community of Australia. Some of these benefits would include public recognition of the DES issue and public interest in the welfare of those exposed. These things would help validate the trauma and alleviate the suffering of those affected. It would also help inform up to 568,000 DES exposed Australians, who still today, are unaware of the fact of their DES exposure, and are suffering the effects of DES without knowing why and what they can do about it. A US Public Apology for DES may even set a precedent for the Australian government to issue a National Apology and go on to formally recognise the rights of Australians to be informed of the possibility of having been DES exposed. Food for thought???

Visit Caitlin's blog post now to check out her options in supporting a US Apology for DES. If you are outside USA and having difficulty with the web forms of Senators Kerry and Brown, you can send a letter to the following addresses:

Senator John Kerry (MA)
United States Senate
218 Russell Senate Office Building
Washington, DC 20510
USA

Senator Scott Brown (MA)
United States Senate
317 Russell Senate Office Building
Washington, DC 20510-2102
USA

Thursday, 12 August 2010

Our Breast Screening Behind The Scenes

In March this year the Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG) reviewed its College Statement (C-Gen 8) Diethylstilboestrol (DES) Exposure in Utero. This Statement now includes information that annual mammography is recommended for women aged 40 and over in view of the recent reports of increased breast cancer risks in these age groups.

The June 2009 BreastScreen Australia Evaluation Final Report (Screening Monograph N0:1/2009, Policy Issue No:6) states: Women who were exposed to DES in utero may have a slightly higher risk of breast cancer. However, the level of risk is similar to exposure to a range of other risks that would not generally require more intensive screening or management protocols.

The Department of Health and Ageing's Cancer Screening Section has been notified by DES Action NSW of this discrepancy regarding screening between the Report and the College Statement. However, no action is intended by the Department on this matter.

DES Action NSW stands by the following information provided by its partner organisation DES Action USA:

DES daughters over age 40 should have a mammogram every year, along with a clinical breast examination (presumably at the same time as her annual DES examination).

Recommendations for DES mothers call for annual breast screenings, including clinical breast examinations and mammograms.

Disturbingly, the 2009 BreastScreen Australia Evaluation Report makes recommendation that women aged 40-44 and women aged 75+ be made ineligible for BreastScreen Services. If implemented, the worst impact would be for the thousands of Australian women who are still unaware of the fact of having been exposed to DES.

DES Action NSW has suggestions to help DES mothers and daughters access annual mammograms at BreastScreen services. To find this information, go to the previous blog item 17/1/09.

Saturday, 31 July 2010

WONDER MONTH FOR WONDER DRUG

July has been the month for wonders for Caitlin McCarthy, screenwriter of the US film in development, WONDER DRUG. Caitlin (in photo) received the award "Most Likely To Be Produced" at the 2010 Action on Film International Film Festival. No doubt she is feeling ecstatic and over the moon. Even a selected scene from WONDER DRUG was screened at this Festival. Caitlin was interviewed following her award achievement and this will be posted on YouTube over the next few weeks.

As we watch WONDER DRUG's development go from strength to strength, all Australians can gain hope for this film's distribution in Australia. The WONDER DRUG film in our country has the potential to end a good deal of unnecessary suffering now and in the future for all unsuspecting DES exposed Australians, who have so far been badly kept in the dark about the dangers of DES.

WONDER DRUG's attention is ever growing with blog posts and media articles. For the full stories about WONDER DRUG and to offer support, see www.facebook.com/wonderdrugthemovie

Monday, 5 July 2010

Diagnosed with DES associated cancer?

Here is some interesting information for DES daughters who have had diagnosis of clear cell adenocarcinoma of the vagina/cervix (CCA).

The Center for Analysis for Rare Tumors (CART-WHEEL) is a project by the Royal Melbourne Hospital to study different kinds of rare tumors. People from all over the world are invited to submit information about about their particular tumor so that researchers can develop new insights into these understudied tumors and this may hopefully lead to better treatments.

You can read all about CART-WHEEL and register for participation in this research study at www.cart-wheel.org
For further information you can contact:
CART-WHEEL
BioGrid Australia
6 North, Main Building
Royal Melbourne Hospital
Grattan St, Parkville 3050
VIC, Australia

Ph: +61 3 93423167
Email: contact@cart-wheel.org

IMPORTANT MEMO
Australian DES daughters diagnosed with CCA are urged to self-report their cases to BOTH the TGA Reporting Adverse Events for Consumers and the DES Cancer Registry Chicago.

DES Action NSW knows of instances where cases have gone unreported by health care providers in Australia. Case reports are crucial to knowing the magnitude of the DES exposure problem in our country.

NY Times - Huge Ad

A full page advertisement by Aaron Levine & Associates was published in New York Times (27/6/10) about litigation opportunity for DES daughters affected by breast cancer. Aaron Levine & Associates is a US team of women's health lawyers, experienced in DES injury litigation and currently concentrating on breast cancer in DES daughters.

This advertisement certainly indicates the saga of suffering due to DES is far from over.

There is more information about legal recourse at the blog item 22/11/08 "Media Alert: Australian woman wins battle against 'wonder drug' makers in United States".

Wednesday, 23 June 2010

DES AWARENESS WEEK

For the past five years we have held the event DES Awareness Week on the Federal and State Health Calendars. This event involves sending media releases and constant messaging to over 1,000 media sources (print, radio, TV). Every year we have a wonderful team of volunteers from different localities across Australia ready to tell journalists a little about their own experience with DES exposure for articles about DES in their own local newspapers. Having articles personalised in this way certainly helps raise interest by media in running the DES story. Here are examples of media interest in DES Awareness Week 2010:

Listen to the ABC Radio Canberra 4/6/10 podcast here

Macedon Ranges Telegraph VIC 1/6/10
www.macedonrangestelegraph.com.au/news/local/news/general/drug-that-destroyed-many-lives/1845176.aspx?src=rss

Maitland Mercury NSW 2/6/10
www.maitlandmercury.com.au/news/local/news/general/mum-daughter-raise-awareness-of-drug/1847036.aspx

We are always looking for volunteers to help us cover the whole of Australia. If you are DES exposed, are able to share some of your story and would like to join our great volunteer team in spreading the message about DES, we would love to hear from you now - contact 02 98754820 or email c_devine@bigpond.net.au

.........and there's more.........

EASYMIX 1467AM Mildura Radio Victoria ran the following:

Health check - Are you affected by DES?
www.easymix.com.au/mildura/index.php?option=com_content&view=article&id=44056:health-check-are-you-affected-by-des&catid=43:local-newsroom&Itemid=86

Tuesday, 15 June 2010 09:56

Australian women and men are being urged to ask their mothers and grandmothers if they took the anti-miscarriage drug DES (diethylstilboestrol or "stilboestrol") as part of this year's DES Awareness Week. It is estimated that 160,000 Australians may be affected by this drug, many of whom are unaware of their exposure and its health risks.

Asking this one simple question could save lives as many Australians still have not heard about DES, an anti-miscarriage drug prescribed in good faith to pregnant women between 1940 and 1971 (and sometimes beyond). Problems first arose with this drug in the 1970s. It is now known to increase risks in certain cancers (breast, cervical and vaginal) and cause reproductive problems in those women given DES and their children of that pregnancy. Many people remain unaware of their exposure to DES and yet, it is vital that people affected get the specialised health care they need. It is important that DES exposed women get the proper screenings to detect cancers early and women exposed to DES in the womb have "high risk" care during their pregnancies. Men exposed to DES in the womb can be affected too, with increased risk of genital abnormalities. They should do self-checks regularly and report anything unusual to their doctors.

Carol Devine, DES Action NSW coordinator, herself a DES daughter, is pinning her hopes on a feature film now under development in USA by screenwriter, Caitlin McCarthy, called "Wonder Drug", a scientific drama about the DES tragedy.

"Raising conversation about the medical history of your mother or grandmother in relation to DES can be difficult, especially when exposure to this drug could involve the health of a loved one. I hope that when this film comes to Australian cinemas, it will encourage families to talk about DES, or trigger a memory for mothers who were prescribed DES from 1940-1971 (and some cases beyond)," she said.

Dr Jules Black, DES knowledgeable obstetrician and gynaecologist and medical spokesperson for the DES Action group, urges women, who have health histories suggestive of DES exposure, eg, recurrent miscarriages, t-shape uterus, ectopic (tubal) pregnancies and infertility to seek DES information and to visit their doctors. Women can ask for an assessment of DES exposure probability and possible referral to a DES knowledgeable specialist.

"Taking DES information along to appointments is very helpful, so that health professionals understand that special cancer preventive care for DES exposed women is important and should be life-long," says Dr Black. "As a result of case reports of DES associated cervical and vaginal cancer in women exposed in the womb in the 50s age group, there is concern for a possible increase in cases as these women get older," adds Dr Black.

The estimate that at least 160,000 people are exposed to DES in Australia is a conservative figure calculated from available data.

People can find out about DES and see the articles about Wonder Drug at www.desnsw.blogspot.com . The website has a listing of DES knowledgeable health care providers in Australia. Information and support is available by phoning DES Action Australia-NSW 02 98754820.

Are you DES exposed?

If you were born between 1938 and 1971 (and in some cases beyond), here is how to find out:
  • Ask your mother if she recalls having a previous miscarriage or being given medications while pregnant. DES was most commonly prescribed to prevent miscarriage and for pregnancy complications such as bleeding. It was also known as "stilboestrol". DES mothers sometimes experience guilt feelings, but should be assured they did what they thought best to preserve their pregnancies and what was the accepted medical standard at the time. DES was also used to stop breastfeeding after giving birth and in the latter years of DES usage, another hormone called progesterone was more commonly used in pregnancy. However, these usages are not known to cause any problems. Even if your mother is no longer alive and remaining relatives offer no information, your own health history may offer clues. If you've had a series of reproductive problems such as cancer, infertility, or endometriosis, among other issues, you may have been exposed before birth.
  • Do your research. If you think you have been affected by DES, ask your doctor for more information, and visit www.desnsw.blogspot.com for support and resources.
  • Think about your health. Health problems associated with DES include risk for miscarriage and ectopic (tubal) pregnancy, premature delivery, infertility, undescended testicles and reproductive tract cancers, primarily of the vagina and cervix.
If you are DES exposed or suspect that you are:
  • Relay this to your health care provider. DES exposure is as important to your health history as conditions like diabetes or heart problems.
  • Mark your diary to have your special DES health checks.
  • Keep updated and talk to your family about DES. Overseas research about DES is ongoing, so it is important for you and your family to keep informed.
  • Seek support if needed.